Edition:
United States

Savara Inc (SVRA.OQ)

SVRA.OQ on NASDAQ Stock Exchange Global Select Market

10.60USD
17 Aug 2018
Change (% chg)

-- (--)
Prev Close
$10.60
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
90,023
52-wk High
$17.11
52-wk Low
$5.07

Select another date:

Wed, May 9 2018

BRIEF-Savara Reports Q1 Loss Per Share $0.88

* SAVARA REPORTS FIRST QUARTER 2018 FINANCIAL RESULTS AND PROVIDES BUSINESS UPDATE

BRIEF-Savara Reports Q4 Loss Per Share $0.23

* SAVARA REPORTS FOURTH QUARTER AND FULL YEAR 2017 FINANCIAL RESULTS AND PROVIDES BUSINESS UPDATE

BRIEF-Savara Initiates Phase 2A Clinical Study Of Molgradex For The Treatment Of Ntm Lung Infection

* SAVARA INITIATES PHASE 2A CLINICAL STUDY OF MOLGRADEX FOR THE TREATMENT OF NTM LUNG INFECTION Source text for Eikon: Further company coverage:

Select another date: